CA2056619A1 - Method of inactivation of viral and bacterial blood contaminants - Google Patents

Method of inactivation of viral and bacterial blood contaminants

Info

Publication number
CA2056619A1
CA2056619A1 CA002056619A CA2056619A CA2056619A1 CA 2056619 A1 CA2056619 A1 CA 2056619A1 CA 002056619 A CA002056619 A CA 002056619A CA 2056619 A CA2056619 A CA 2056619A CA 2056619 A1 CA2056619 A1 CA 2056619A1
Authority
CA
Canada
Prior art keywords
method
viral
inactivation
bacterial blood
blood contaminants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002056619A
Other languages
French (fr)
Other versions
CA2056619C (en
Inventor
Roger W. Hackett
Raymond P. Goodrich, Jr.
Marjan Van Borssum Waalkes
Victoria A. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Roger W. Hackett
Raymond P. Goodrich, Jr.
Marjan Van Borssum Waalkes
Victoria A. Wong
Cryopharm Corporation
Credit Management Solutions, Inc.
Baxter International Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US51023490A priority Critical
Priority to US63227790A priority
Priority to US632,277 priority
Priority to US510,234 priority
Application filed by Roger W. Hackett, Raymond P. Goodrich, Jr., Marjan Van Borssum Waalkes, Victoria A. Wong, Cryopharm Corporation, Credit Management Solutions, Inc., Baxter International Inc. filed Critical Roger W. Hackett
Priority to PCT/US1991/002504 priority patent/WO1991016060A1/en
Publication of CA2056619A1 publication Critical patent/CA2056619A1/en
Application granted granted Critical
Publication of CA2056619C publication Critical patent/CA2056619C/en
Anticipated expiration legal-status Critical
Application status is Expired - Fee Related legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029Radiation
    • A61L2/0035Gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029Radiation
    • A61L2/0041X-rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/22Blood or products thereof

Abstract

A method is provided for inactivating viral and/or bacterial contamination in blood cellular matter, such as erythrocytes and platelets, or protein fractions. The cells or protein fractions are mixed with chemical sensitizers and irradiated with, for ex-ample, gamma or X-ray radiation.
CA 2056619 1990-04-16 1991-04-16 Method of inactivation of viral and bacterial blood contaminants Expired - Fee Related CA2056619C (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US51023490A true 1990-04-16 1990-04-16
US63227790A true 1990-12-20 1990-12-20
US632,277 1991-02-15
US510,234 1991-02-15
PCT/US1991/002504 WO1991016060A1 (en) 1990-04-16 1991-04-16 Method of inactivation of viral and bacterial blood contaminants

Publications (2)

Publication Number Publication Date
CA2056619A1 true CA2056619A1 (en) 1991-10-17
CA2056619C CA2056619C (en) 2002-07-30

Family

ID=27056837

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2056619 Expired - Fee Related CA2056619C (en) 1990-04-16 1991-04-16 Method of inactivation of viral and bacterial blood contaminants

Country Status (2)

Country Link
JP (1) JP3373201B2 (en)
CA (1) CA2056619C (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171549B1 (en) 1993-07-22 2001-01-09 Sterisure, Inc. Method for sterilizing products
US6682695B2 (en) 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US6908591B2 (en) 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US7848487B2 (en) 2001-09-24 2010-12-07 Clearant, Inc. Methods for sterilizing biological materials containing non-aqueous solvents

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171549B1 (en) 1993-07-22 2001-01-09 Sterisure, Inc. Method for sterilizing products
US6346216B1 (en) 1993-07-22 2002-02-12 Clearant, Inc. Method for sterilizing products
US6635222B2 (en) 1993-07-22 2003-10-21 Clearant, Inc. Method of sterilizing products
US6682695B2 (en) 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US7848487B2 (en) 2001-09-24 2010-12-07 Clearant, Inc. Methods for sterilizing biological materials containing non-aqueous solvents
US6908591B2 (en) 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient

Also Published As

Publication number Publication date
CA2056619C (en) 2002-07-30
JP3373201B2 (en) 2003-02-04
JPH05500971A (en) 1993-02-25

Similar Documents

Publication Publication Date Title
CA2027595C (en) Sterile product and method for sterilizing and assembling such product
AU562603B2 (en) Point source x-ray focussing device
AU590759B2 (en) Fluid treatment process and apparatus
AU558282B2 (en) Infrared radiation source arrangement
AU560045B2 (en) Latex graft copolymer containing aldehyde realtive with biological agents
DE3569473D1 (en) Method for inactivating pathogens in blood products
AU670743B2 (en) Using 5,10,15,20-tetrakis(r-carboxyphenyl)porphine for detecting and treating lung cancer
RU94022258A (en) New sulfonylaminopyrimidines
EP0425593A4 (en) Irradiation of blood products
DE3069426D1 (en) Microparticles, their preparation and their biological uses, especially in the culture of diploid cells
EP0330966A3 (en) Process for the preparation of polyisocyanates containing isocyanurate groups, and their use
AU6626994A (en) Culture medium for rapid count of coliform bacteria
EP0299517A3 (en) Long-test-film cassette for biochemical analysis, and system for loading the same
DE3177275D1 (en) Using triazolylaethanol derivatives and their compositions as non-agricultural fungicides.
AU4301389A (en) Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids
CA2031803A1 (en) Improvements in or relating to glycopeptide deriveratives
AU5655290A (en) Precipitate test for microorganisms
AU659797B2 (en) Analyte determination in biological fluids in the presence of interfering substances
AU2927784A (en) Sterile connection process
AU583188B2 (en) Method and apparatus for seeking target address with error check code
PT79187A (en) Process for preparing 1-heteroaryl-4-<(2,5-pyrrolidinedion-1-yl)-alkyl>-piperazine derivatives and of pharmaceutical compositions containing the same
AU7813191A (en) Novel immunoconjugates and methods for their use in tumor therapy
AU8438591A (en) X-ray analysis apparatus
JPH06500805A (en)
SE8201554L (en) Seen up to Stella substances produced by cells

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed